Synopsys (NASDAQ:SNPS – Get Free Report) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.370-3.420 for the period, compared to the consensus EPS estimate of 3.370. The company issued revenue guidance of $1.6 billion-$1.6 billion, compared to the consensus revenue estimate of $1.6 billion. Synopsys also updated its FY 2025 guidance to 14.880-14.960 EPS.
Synopsys Price Performance
NASDAQ SNPS traded up $1.07 during trading hours on Friday, reaching $455.78. 413,075 shares of the company’s stock traded hands, compared to its average volume of 1,114,278. Synopsys has a 52-week low of $454.05 and a 52-week high of $624.80. The firm has a 50-day simple moving average of $506.84 and a 200 day simple moving average of $516.13. The firm has a market cap of $70.45 billion, a PE ratio of 31.39, a PEG ratio of 3.23 and a beta of 1.12.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the stock. Rosenblatt Securities reiterated a “buy” rating and issued a $660.00 price target on shares of Synopsys in a research report on Tuesday. Loop Capital initiated coverage on Synopsys in a research report on Monday, November 11th. They set a “buy” rating and a $675.00 target price for the company. Robert W. Baird decreased their price target on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Piper Sandler dropped their price objective on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating for the company in a research note on Thursday. Finally, Morgan Stanley decreased their target price on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a research report on Monday. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $638.58.
Insider Activity at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.62% of the stock is currently owned by corporate insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Dividend Capture Strategy: What You Need to Know
- 5 Best Gold ETFs for March to Curb Recession Fears
- Options Trading – Understanding Strike Price
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- What is Put Option Volume?
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.